Skip to main content
SpringerLink
Log in

Effects of potassium ethylxanthogenate and 2,3-dimercaptopropane sulphonate sodium on the pentobarbital pharmacokinetics and metabolism in male mice

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The effects of potassium ethylxanthogenate (PEX) and 2,3-Dimercaptopropane sulphonate sodium (Unithiol) on the pentobarbital (40 mg/kg, body weight i.v.) (PB) sleeping time, pharmacokinetics, and metabolism, were studied in comparative experiments on male albino mice.

It was established that the preatretment of animals with PEX (80 mg/kg of body weight s.c.) potentiated the PB sleeping time. Unithiol in an equimolar dose (105.2 mg/kg of body weight s.c.) had no effect. The pharmacokinetics of PB could be fitted to a biexponential equation of the type Cp(t)=A.e−αt+B.e−βt. PEX caused an almost two-fold decrease in the elimination rate constant of plasma PB, which led to a higher half-time and a lower total clearance compared with the controls. The curve for the plasma PB metabolites in the PEX-pretreated mice was significantly lower than of the controls. A higher PB level and decreased rate of elimination in PEX-pretreated animals was observed also in the: liver, lungs, kidney, and brain.

A conclusion was drawn that the potentiating effect of PEX on the PB sleeping time is mainly due to inhibition of PB liver metabolism. It was suggested that the differences in the biological effects of the two thiol compounds are due to the differences in their chemical structures: PEX possesses a C=S group but Unithiol lacks this group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Giarman, N.J., Flick, F.H. and White, J.M. (1951): Prolongation of Thiopental Anesthesia in the mouse by Premedication with Tetraethylthiuram Disulfide («Antabuse»). Science,114, 35–36.

    Article  CAS  PubMed  Google Scholar 

  2. Winters, W., Shideman, F.E., Richards, R.K.Y, and Taylor, J.D. (1952): Influence of Tetraethylthiuram disulfide (Antabus) on Duration of action of Thiopental, Proc. Soc. exp. Biol.,81, 576–578.

    CAS  Google Scholar 

  3. Korablev, M.V. (1962): Influence of sulfur-containing compounds and urea on drug induced sleep. Farmacol. Toxicol.,1, 47–55.

    Google Scholar 

  4. Kahn, J.B. (1953): Effect of Dimercaprol on the metabolism of pentobarbital in mice. J. Pharmacol. exp. Ther.109, 292.

    CAS  PubMed  Google Scholar 

  5. Lange, P. und Jung, F. (1971): Die Verringerung der Lebertoxizität von Tetrachlorkohlenstoff durch Diäthyldi thiokarbamat und 3-(0-Totyl)-4-(nitro)-sydnon. Acta Biol. Med. Germ.27, 425–434.

    CAS  PubMed  Google Scholar 

  6. Mayer, O. and Eyble, V. (1973): Dithiocarbamate central effects in relation to their possible influence on drug metabolizing enzymes. J. Pharm. Pharmacol.,25, 672–676.

    CAS  PubMed  Google Scholar 

  7. Stoytchev, Ts. (1958): Experimental studies on the toxicity of potassium ethylxanthögenate and its anti-dotal effect in acute sublimate poisoning. Savr. Med. (Balg)2, 19.

    Google Scholar 

  8. Stoytchev, Ts. (1963): Antidotal effect of sodium and potassium ethylxanthögenate in acute mercury poisoning of rabbits. Exp. Med. Morphol. (Bulg),4, 35.

    Google Scholar 

  9. Mitcheva, M., Yanev, S. and Stoytchev, Ts. (1976): Influence of potassium ethylxanthögenate on hexobarbital metabolism. Farmac.26, 45–48.

    Google Scholar 

  10. Kuntzman, R., Ikeda, M., Jacobson, M. and Conney, A.H. (1967): A sensitive method for the determination and isolation of pentobarbital-C14 metabolites and its application to in vitro studies of drug meta-bolism. J. Pharmac. exp. Ther.,157, 220.

    CAS  Google Scholar 

  11. Hess, R., Leschem, D., Teschemacher, H. and Herz, A. (1972): A simple method for the separate Estimation of Labelled Drugs and their Metabolites by liquid Scintillation Counting. Some Practical Examples. Eur. J. Clin. Pharmacol.,5, 104.

    Article  CAS  Google Scholar 

  12. Cochin, J., Daly, J.M. (1963): The use of thinlayer chromatography for the analysis of drugs. Isolation and identification of barbiturates and non-barbiturate hypnotics from urine, blood and tissues. J. Pharmacol, exp. Ther.,139, 154–159.

    CAS  Google Scholar 

  13. Boxenbaum, H.G., Riegelman, S. and Elashoff, R.M. (1974): Statistical Estimation in Pharmacokinetics. J. Pharmacokin. Biopharmacent.2, 123–148.

    Article  CAS  Google Scholar 

  14. Stoytchev, Ts., Koleva, M. and Kirova, A. (1974): Influence of Potassium ethylxanthogenate and Unithiol on the amphetamine-induced locomotor activity, hexobarbital sleeping time and dopamine -β-hydroxylase activity. Proceed. Eur. Soc. Drug. Tox.,15, 315–319.

    Google Scholar 

  15. Ossenberg, F., Plignoux, M., Bourdian, D. and Benhamon, J. (1975): Pentobarbital pharmacokinetics in the normal and in the hepatectomized rat. J. Pharmacol, exp. Ther.,194, 111–116.

    CAS  Google Scholar 

  16. Ehrnebo, M. (1974): Pharmacokinetics and distribution properties of pentobarbital in human following oral and intravenous administration J. Phar-Sci.,63, 1114–1118.

    Article  CAS  Google Scholar 

  17. Saubermann, A.J., Gallagher, M.L. and HedleyWhyte, J. (1974): Uptake, Distribution and Anesthetic effect of Pentobarbital-2-C 14 after Intravenous Injection into mice. Anesthesiology,40, 41–51.

    Article  CAS  PubMed  Google Scholar 

  18. Goldstein, A. and Aronow, L. (1960): The Duration of Action of Thiopental and Pentobarbital. J. Pharmacol, exp. Ther.,128, 1.

    CAS  Google Scholar 

  19. Allain, P., Premel-Cabic, A., Cabares, J. and Lechat, P. (1975): Influence de l’administration préalable de Chlorure d’aluminium sur l’activité de quelques hypnotiques chez la souris. J. Pharmacologie (Paris),6, 33–40.

    CAS  Google Scholar 

  20. Cooper, J.R. and Brodie, B.B. (1957): Enzymatic oxidation of pentobarbital and thiopental. J. Pharmacol, exp. Ther.120, 75–83.

    CAS  Google Scholar 

  21. Matthew, H. (1971): Acute barbiturate poisoning. Excerpta medica, Amsterdam.

    Google Scholar 

  22. Titus, E. and Weiss, H. (1955): The use of biologically prepared radioactive indicators in meta-bolic studies metabolism of pentobarbital. J. Biol. Chem.214, 807–821.

    CAS  PubMed  Google Scholar 

  23. Glasson, B. and Benakis, A. (1966): Aspect biochimique de la potentialisation par le SKF-525-A du pentobarbital et du Glior. Helv. Physiol. Pharmacol. Acta,24, C 24–29.

    Google Scholar 

  24. Jori, A., Bianchetti, A. and Prestini, P.E. (1970): Relations between barbiturate brain levels and sleeping time in various experimental conditions. Biochem. Pharmacol.,19, 2687–2694.

    Article  CAS  PubMed  Google Scholar 

  25. Kato, R., Takanaka, A. and Onodo, K. (1969): Individual difference in the effect of drugs in relation to the tissue concentration of drugs. Jap. J. Pharmacol.19, 260–267.

    Article  CAS  PubMed  Google Scholar 

  26. Plevova, J., Frantik, E. and Chladkova, D. (1973): The effect of an acute carbon disulphide exposure on the pentobarbital sleep and kinetics in rats. Activ. Neur. Sup. (Praha),15, 137.

    CAS  Google Scholar 

  27. Stromme, H.H. (1965): Metabolism of Disulfiram and DDC in rats with demonstration of an in vivo ethanol-induced inhibition of the glucuronic acid conjugation of the thiol. Biochem. Pharmacol.14, 393.

    Article  CAS  Google Scholar 

  28. Dalvi, R., Hunter, A.C. and Neal, R.A. (1975): Toxicological implications of the mixed-function oxidase catalyzed metabolism of carbon disulfide. Chem. Biol. Interact.10, 347.

    Article  CAS  PubMed  Google Scholar 

  29. Hunter, A. and Neal, R.A. (1975): Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thionosulfur-containing compounds. Biochem. Pharmacol.,24, 2199–2205.

    Article  CAS  PubMed  Google Scholar 

  30. Merlevede, E. and Peters, J. (1965): Métabolisme des xanthates chez l’homme et chez le cobaye. Arch. Belges Med. Soc.23, 513–551.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dep. Pharmacology, Institute of Physiology, Bulgarian Academy of Sciences, 1113, Sofia, Bulgaria

    S. Yanev & Ts. Stoytchev

  2. Institute of Pharmacology, Czechoslovak Academy of Sciences, Praha, Czechoslovakia

    I. Janku, I. Havlik & V. Krebs

Authors
  1. S. Yanev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Janku
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ts. Stoytchev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Havlik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Krebs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yanev, S., Janku, I., Stoytchev, T. et al. Effects of potassium ethylxanthogenate and 2,3-dimercaptopropane sulphonate sodium on the pentobarbital pharmacokinetics and metabolism in male mice. European Journal of Drug Metabolism and Pharmacokinetics 7, 21–29 (1982). https://doi.org/10.1007/BF03189539

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189539

Key words

Search

Navigation